Qu Biologics Inc. EP3137108A1 Anti-Microbial Immunomodulation
Summary
The European Patent Office published EP3137108A1 on April 15, 2026, titled 'ANTI-MICROBIAL IMMUNOMODULATION.' The patent application, filed by Qu Biologics Inc., names inventors Harold David Gunn, Salim Dhanji, and David W. Mullins. The invention is classified under IPC categories A61K 39/108, A61K 39/00, A61P 31/04, and A61P 31/12. Designation extends across all relevant European member states including DE, FR, GB, IT, NL, ES, PL, and 24 others.
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 49 changes logged to date.
What changed
The EPO published patent application EP3137108A1 for Qu Biologics Inc. covering anti-microbial immunomodulation technology. The publication includes full applicant and inventor details (Harold David Gunn, Salim Dhanji, David W. Mullins) and International Patent Classification codes A61K 39/108, A61K 39/00, A61P 31/04, and A61P 31/12. The patent is designated across 35 European member and extension states.
For competitors in the immunomodulation or anti-microbial therapeutic space, this publication signals an active patent application by Qu Biologics Inc. in the European market. Parties developing similar technologies should review the published claims upon availability to assess potential freedom-to-operate concerns in EU jurisdictions.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-MICROBIAL IMMUNOMODULATION
Publication EP3137108A1 Kind: A1 Apr 15, 2026
Applicants
Qu Biologics Inc.
Inventors
GUNN, Harold David, DHANJI, Salim, MULLINS, David W.
IPC Classifications
A61K 39/108 20060101AFI20170824BHEP A61K 39/00 20060101ALI20170824BHEP A61P 31/04 20060101ALI20170824BHEP A61P 31/12 20060101ALI20170824BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.